Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06087991 · ClinicalTrials.gov registry record
Buprenorphine Induction and Naloxone Distribution Program-Combined With Warm Hand-Off Referral to Continued Treatment
A clinical trial, sponsored by Jerry Cochran.
- Completed
- Registry status
- 65
- Enrollment target
NCT06087991 is a clinical trial that has completed, run by Jerry Cochran. The registered enrollment target is 65 participants.
The verdict
NCT06087991 has completed, sponsored by Jerry Cochran.
- COMPLETED
- Registry status
- 65 participants
- Enrollment target
Study Summary
This study is a collaboration between the University of Utah and Castleview Hospital in Price, Utah. Buprenorphine is a medication approved by the FDA to treat Opioid Use Disorder (OUD). Castleview Hospital currently does not prescribe buprenorphine in the emergency department (ED) instead it refers patients to outside addiction treatment facilities. This is a service focused project which the University of Utah will provide mentoring and education to Castleview in implementing an in ED buprenorphine/naloxone distribution program along with referral to continued services. After the program has been implemented, the investigators will evaluate it using quantitative surveys of program participants and qualitative interviews of hospital staff and stakeholders.
Interventions
- BEHAVIORAL Implementation of the BINDeR-Tx service model
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2023-04-01 |
| Est. Completion | 2024-10-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06087991
The ClinicalTrials.gov registry entry for NCT06087991 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jerry Cochran, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Implementation of the BINDeR-Tx service model is the first listed.
NCT06087991 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06087991 about?
NCT06087991 is a clinical study titled "Buprenorphine Induction and Naloxone Distribution Program-Combined With Warm Hand-Off Referral to Continued Treatment". This study is a collaboration between the University of Utah and Castleview Hospital in Price, Utah. Buprenorphine is a medication approved by the FDA to treat Opioid Use Disorder (OUD). Castleview Hospital currently does not prescribe buprenorphine in the emergency department (ED) instead it refer...
What is the current status of trial NCT06087991?
This trial is currently completed. The enrollment target is 65 participants. The study started on 2023-04-01. Estimated completion is 2024-10-01.
What interventions are being tested in trial NCT06087991?
The interventions under investigation include: Implementation of the BINDeR-Tx service model (BEHAVIORAL).
Who is sponsoring clinical trial NCT06087991?
This trial is sponsored by Jerry Cochran, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.